Drug intelligence / Profile preview

paracetamol + caffeine

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Paracetamol + caffeine is a fixed-dose combination of two active ingredients: paracetamol (also known as acetaminophen), an analgesic and antipyretic, and caffeine, a central nervous system stimulant. This combination is primarily used for the short-term relief of moderate pain such as headaches, migraines, muscle aches, menstrual pain, toothaches, backaches, colds and sore throats. Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system or by activating descending serotonergic pathways to reduce pain perception. Caffeine acts as a vasoconstrictor in the brain to reduce headache and also enhances the analgesic effect of paracetamol[1][2][5]. The combination provides more effective symptom management than either agent alone.

Brand names
DoloDoloparStopacheNovalgin NUCafiparCipmolZimalginTrimol SBinilonParatuf Active
Other names
acetaminophen + caffeine
02

Targets

ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on paracetamol + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call